Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Citrate vs Heparin Anticoagulation in Hemodialysis with Theranova Membrane
NCT04139525Unknown
- Start
- Sep 2020
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of trisodium citrate in end stage renal disease (ESRD). Primary endpoints: Clearance of beta-2 microglobulin, Clearance of phosphate and 4 more. Status: unknown.
02
Drugs
trisodium citrate
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT04139525.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04139525.